Business
The New York Academy of Sciences Collaborates with Resverlogix to Host Epigenetics Symposium
The New York Academy of Sciences Collaborates with Resverlogix to Host Epigenetics Symposi...
About this update from Resverlogix Corp.
[{"type":"text","content":"\n\n\n\nThe New York Academy of Sciences Collaborates with Resverlogix to Host Epigenetics Symposium\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nThe New York Academy of Sciences Collaborates with Resverlogix to Host Epigenetics Symposium\nCanada NewsWire\nCALGARY, April 18, 2016\n\n\n\nResverlogix to chair and present at The New York Academy of Sciences' symposium \"Epigenetics: Cancer & Beyond\"\n\n\n\nCALGARY, April 18, 2016 /CNW/ - Resverlogix Corp. (\"Resverlogix\" or the \"Corporation\") (TSX:RVX) is pleased to announce its participation in the upcoming symposium Epigenetics: Cancer and Beyond at The New York Academy of Sciences on Thursday, April 28, 2016, from 9am-5pm (EST) in New York City. An international assembly of biomedical investigators will convene to explore the therapeutic potential of pharmacologic modulation of the epigenome. Epigenetics – meaning 'above the genome' describes the mechanisms by which modifications are made to our biological building blocks that determine gene expression. Notably, abnormalities in the epigenome have been identified in many diseases, providing a promising new path for drug discovery.\n\nInternationally renowned expert in the field of cancer research, Dr. Craig B Thompson, Memorial Sloan Kettering Cancer Center, will deliver the keynote address at the symposium which will be chaired by Dr. Norman Wong, Chief Scientific Officer of Resverlogix and Dr. Dominique Verhelle of Third Rock Ventures. \n\nAcademia and industry come together to share cutting edge perspectives from the field of epigenetics, in which Dr. Ewelina Kulikowski, Senior Vice President of Research & Development will present on behalf of Resverlogix. Additional speakers include: Dr. Michael Elowitz, California Institute of Technology, Dr. Keiko Ozato, National Institute of Child Health and Human Development, Dr. Roberto Pili, Indiana University School of Medicine, Dr. Patrick Trojer, Constellation Pharmaceuticals, Dr. Christopher Vakoc, Cold Spring Harbor Laboratory, Daniel Vitt, 4SC AG, and Dr. Eric Campeau...